Alkem Laboratories Limited is a well-known Indian pharmaceutical company that develops, manufactures and sells medicinal drugs and nutraceutical products.Market Capitalisation
The market capitalisation of Alkem Laboratories, as of July 30 2018, was a little over Rs.25,281 crore.
Alkem Laboratories Limited has been manufacturing generic drugs, pharmaceutical ingredients, branded generics, and nutraceuticals. The company markets products in India and also in more than 50 countries across the globe. With a strong sales and distribution network, Alkem is recognised as an industry leader in segments such as pain management, nutrients, minerals and vitamins and gastrointestinal verticals. The company has had as many as 14 manufacturing units across India and two units in the USA. There are strict quality control practices that are being followed at all of their manufacturing units.
Incorporated as Alkem Laboratories Limited in 1973, the company set up its first plant five years later in Mumbai. In 1992, a manufacturing unit was established in Gujarat. Soon after, the firm invested in setting up a research and development centre at Taloja, Mumbai in 2003. Three years later, their anti-infective drug Taxim became the first such drug to hit the Rs.1,000 million sales mark in the country. The next year, the firm filed its first Abbreviated New Drug Application (ANDA) in the United States of America (USA) for Amlodipine. In 2009, Amlodipine got the ANDA nod. From 2009 to 2015, Alkem acquired various companies such as Ascend Laboratories, Pharmacor PTY Ltd., Enzene, Clindac-A, and other API manufacturing units. In 2015, the company successfully made its debut in the stock market by making its Initial Public Offering (PIO).
Mr.Samprada Singh - Chairman Emeritus
Mr.Samprada Singh is a co-founder of Alkem and has more than 43 years of experience in this segment. Singh has been a recipient of esteemed awards such as the ‘Lifetime Achievement Award', ‘Asian Grid Leadership Lifetime Achievement Award 2006', and the ‘Lifetime Contribution Award'. In 2016, he was given the ‘EY Entrepreneur of the Year Award in Life Sciences'
Mr. Basudeo N. Singh – Executive Chairman
With around 40 years of experience in the pharma segment in India, Singh is also one among the co-founders. From 2007 to 2009, he served as the resident of the Indian Drug Manufacturer's Association. He has also won prestigious laurels for his contribution to the field. In 2014, he was the recipient of the ‘Business Leader of the Year' award.
Mr. Sandeep Singh – Managing Director
Mr.Sandeep was appointed as a board member in 2013 and is presently serving as the Managing Director of the company. He comes with close to a decade of experience in the pharma sector. Mr.Sandeep takes care of domestic and international operations. He was given the ‘Emerging Pharma Leaser of 2016' award, which was bestowed by the Ministry of Health and Family Affairs, Government of India.
Mr. Dhananjay Kumar Singh – Joint Managing Director
Mr.Dhananjay Kumar Singh, who became a board member in 1988, is currently serving as the Joint Managing Director of Alkem. He has more than 30 years of experience in this sector and is presently overseeing the Pharma, Forgen, Arise and Bergen segments in the domestic market. He is actively involved in human resource management, legal aspects, secretarial and compliance, commercials, purchases, distribution, and logistics.
Alkem Laboratories Stock Listings in NSE, BSE, and Indices
Alkem Laboratories equity shares are available for trading on the country's two major stock markets - the National Stock Exchange of India Limited and the Bombay Stock Exchange. The respective codes for the same are as follows:
NSE Code: ALKEMQ
BSE Code: 539523
Sector: PharmaceuticalsComing to the stock market indices, Alkem comprises the following indices:
Nifty Full Midcap 100
Nifty India Consumption
Nifty LargeMidcap 250
Nifty Midcap 100nifty Midcap 150
Nifty MidSmallcap 400
S&P BSE 150 MidCapn Index
S&P BSE 200
S&P BSE 259 largeMidCap Index
S&P BSE 400 MidSMallCap Index
S&P BSE 500
S&P BSE AllCap
S&P BSE Healthcare
S&P BSE LargeMidCap
S&P BSE Mid Cap
S&P BSE MidSmallCap
Alkem Laboratories Limited
Devashish Building, Alkem House,
Senapati Bapat Road, Lower Parel,
Mumbai - 400 013.
Tel: +91 22 3982 99 99
Stock market investments require a lot of research and knowledge. They do not generally offer any tax benefits and are regarded as high-risk investments. Hence,it is crucial to have a diversified portfolio. At Bankbazaar, we encourage our readers to invest on mutual funds.It doesn't require a lot of knowledge and equity linked mutual fund schemes offer tax benefits. Additionally, since mutual funds comprise stocks from multiple companies, they help in building a diversified portfolio.DISCLAIMER:
The contents of this post/blog does not constitute financial or other professional advice nor does it imply in any manner a principal-agent relationship, and is not a professional advice on a specific financial matter.